Austedo 36 mg prolonged-release tablets Austedo 42 mg prolonged-release tablets Austedo 48 mg prolonged-release tablets

Licence holder

TEVA GmbH (all products →)

Active substance

Deutetrabenazine

Dosage form

Prolonged-release tablet

Route of administration

Oral use

ATC code

N07XX16

First authorised

08/01/2026

Prescription status

Product subject to prescription which may not be renewed (A)

Supply

Supply through pharmacies only

Legal basis

Known active substance (Article 8(3) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.